Neither GPs nor LPs seem to be particularly satisfied with the way LP advisory committees (LPACs) function. In 2019, the Institutional Limited Partners Association (ILPA) issued its Principles 3.0, which optimistically observed that the “[PE] industry has made meaningful strides in instituting standardized approaches to [LPACs].” Yet recently, an Institutional Investor article asked, “These Boards are Meant to Protect PE Investors. Why Can’t Anyone Agree on How?” “Each of these is kind of a negotiated deal. There’s no industry standard,” the article quotes an institutional investment manager, noting – without irony – that this individual “sits on about 60 LPACs.” When the SEC adopted the since-vacated private fund adviser rules, the agency had no illusions about the effectiveness of LPACs:
[T]hese types of bodies may not have sufficient independence, authority, or accountability to oversee and consent to these conflicts. Such LPACs . . . do not have a fiduciary obligation to the private fund investors. To the extent investors are afforded LPAC representation or similar rights, certain fund agreements may permit such investors to exercise their rights in a manner that places their interests ahead of the private fund or the investors as a whole. For example, certain fund agreements state that . . . LPAC members owe no duties to the private fund or to any of the other investors in the private fund and are not obligated to act in the interests of the private fund or the other investors as a whole.
Dissatisfaction with current LPAC practices is not limited to under– or unrepresented LPs. As LPACs have evolved from serving advisory roles to performing a range of approval rights, GPs’ frustrations with delays and other dysfunction in the decision-making process have grown correspondingly.
This article argues that the inclusion of independent members on the LPAC – i.e., members that are not affiliated with the GP or any LP – would address a number of the deficiencies in current LPAC practices, resulting in improvements to fund governance practices that would inure to both GPs and LPs.
See “LPAC by Design: Six Recommendations for GPs to Define LPAC Features During Fund Formation” (Feb. 25, 2020).
Current Practice and Deficiencies
LPAC Composition
GPs typically grant LPAC seats to LPs who request them at the fund formation stage and have the negotiating leverage to insist on their request being accepted. The leverage usually derives from the size of an LP’s commitment to the current fund, the amount of the LP’s aggregate commitments to several funds managed by the GP and the prospect of the LP issuing larger commitments to future funds. Despite ILPA encouraging GPs and LPs to allocate seats to ensure the LPAC represents the diversity of the LP base at large, in reality, LPACs rarely do. The only ILPA recommendation that seems to be followed in practice is that LPACs do not include representatives of the GP or its affiliates.
Although there was a time when LPACs became unmanageably large, they now mostly seem to comprise 5‑15 members. As funds frequently have hundreds of LPs, that means the vast majority of investors are not represented on the LPAC. In addition, LPs with large commitments are often among the largest LPs in multiple funds and thus represented on multiple LPACs, with corresponding attention deficits. The fact that one individual sits on 60 LPACs – as referenced in the aforementioned Institutional Investor article – should give pause to the entire industry.
Each LPAC member generally has one vote, and matters before the LPAC are approved by majority vote. In other words, voting power is not proportional to capital commitments.
See “Evolution of LPACs: Trends Toward Robust Procedures and Accountability for LPAC Members (Part One of Two)” (Oct. 8, 2019).
Scope of Approval Rights
The shortcomings in how LPACs are structured and operated have become more apparent – and the need for improvements has gained urgency – as the scope of approval rights granted to LPACs by fund agreements has increased over the last few years. They typically include:
- affiliate transactions;
- investments in excess of concentration or other allocation limits (e.g., geographical restrictions);
- investments outside the defined investment focus;
- key person successions and GP ownership changes;
- extensions of commitment periods and fund terms;
- waivers of thresholds when launching successor funds; and
- the incurrence of fund debt outside permitted parameters.
LPACs’ approval of affiliate transactions is particularly growing in importance as the volume of continuation funds has steadily increased, along with the ongoing consolidation of portfolio companies held by different funds of the same GP and other interfund transactions.
Conflicts of Interest
The SEC was correct in its observations about the limited duties of LPAC members. Fund agreements consistently provide that LPAC members do not have fiduciary duties and, as long as they act in good faith, they can place the interests of the nominating LP ahead of the interests of the fund or the other LPs.
One of the most frequently noted deficiencies is the way LPAC members’ conflicts of interests are addressed. ILPA’s Principles 3.0 recommend:
Either the GP or the LPAC member in question should disclose when an individual LPAC member has a conflict of interest that relates to the matter under consideration, e.g., the LPAC member being a potential lender to a portfolio company, co‑investment for secondary investment activity alongside the fund, investments in prior funds, ownership of an interest in the management company, etc. GPs should remind LPAC members of relevant conflicts of interest prior to votes being held.
See this two-part series on ILPA’s Principles 3.0: “PE Economics and Related Fund Provisions” (Jul. 30, 2019); and “Fund Governance and Disclosures” (Aug. 6, 2019).
It is easy to add more examples of conflicts of interest to ILPA’s list. For instance, an LP planning to invest in a continuation fund may also be represented on the LPAC of the exiting fund. Also, large LPs are often represented on the LPACs of successive funds, which places them on both sides of interfund transactions.
Notably, ILPA’s recommendation to disclose conflicts of interest is not followed with any consistency. A main reason is that the consequences of any disclosure are unclear, as are the consequences of any failure to disclose. Not even ILPA recommends that LPAC members recuse themselves from voting on matters for which they have a conflict of interest. Further, failure by an LPAC member to disclose a conflict does not affect the validity of his or her vote.
Complaints that LPAC practices lack standardization miss the point, as the practices described above are actually quite uniform across funds and their managers. The real issues are LPACs’ inherent structural deficiencies: no representation of a majority of LPs, no fiduciary duties and no protocol for mitigating conflicts of interest.
See “Evolution of LPACs: Grappling With GP and LPAC‑Member Conflicts of Interest While Avoiding Liability (Part Two of Two)” (Oct. 15, 2019).
LP Dissatisfaction
If conflicted LPAC members, regardless of disclosure, can still vote without the confines of fiduciary duties, then disclosure is merely a courtesy rather than a requirement. The result is that non-member LPs are forced to bear the consequences of the industry’s dismissive treatment of LPAC conflicts of interests.
For example, the Institutional Investor reported that “LPs are often left to find out themselves what conflicts exist,” and quoted a frustrated investor who lamented, “we’re invested in just this fund, not all funds[,] . . . [but] have to think about what other LPAC members are doing because they may be invested in three funds.” In addition, anecdotes abound about LPAC members’ reluctance to participate in crucial decisions out of fear that may expose the appointing LP to GP liability, which slows down decision making.
Benefits of Independent Members
Although there is no data available on the point, anecdotally it seems that current LPACs rarely, if ever, include independent members. The reality, however, is that the inclusion of one or two independent members with PE experience on an LPAC would address or at least mitigate the inherent deficiencies of historical LPAC practices.
Independent LPAC members would likely add value to the process in multiple ways:
- improving communication among LPAC members, as well as between a GP and the LPAC;
- adding an objective perspective; and
- accelerating the speed of decision making.
To better understand the potential value of including independent members as LPAC members, it is helpful to consider private company boards. In KPMG’s “2023 Private Company Board Survey Insights,” nearly 90% of respondents said that their boards included at least one independent director, which was defined as a director who is not an executive and not affiliated with the company through an ownership interest.
The following chart shows the KPMG survey results in response to the question “Where do you believe an independent director can add the most value to the business?,” together with an annotation for the potential application to independent LPAC members.
|
KPMG Private Board Survey |
Potential Application to Independent LPAC Members |
|
|
Serving as a sounding board for executives. |
77% |
Yes. GPs may be more inclined to test the waters with an independent member before taking a matter to the full LPAC. |
|
Advising on strategy. |
75% |
Potentially. Consistent with an LPAC’s function, its independent members should not get involved in investment strategies. Independent members can, however, weigh in on strategic matters affecting the fund itself – e.g., when to launch a successor fund or how to approach co‑investment opportunities. |
|
Balancing the views of management and owners with an independent perspective. |
75% |
Yes, in the sense that LPs own the fund and independent LPAC members can mediate between LPs and the GP. |
|
Helping to improve board effectiveness, functioning and process. |
51% |
Yes. Independent LPAC members can act without fear of exposure to GP liability. |
|
Focusing an oversight of financial reporting and risk management. |
45% |
Unlikely. LPACs are involved in valuation questions, but independent members should not have an incremental role compared to the full LPAC. |
|
Overseeing CEO succession. |
43% |
Unlikely. The equivalent would be key person successions, but independent members should not have an incremental role compared to the full LPAC. |
|
Serving as a board committee chair. |
23% |
Potentially, for example, if the LPAC forms a committee in connection with a continuation fund or interfund transaction. |
|
Serving on a special committee. |
19% |
Potentially. See above. |
|
Serving as board chair. |
16% |
Potentially. |
An equally important benefit is that independent LPAC members give a voice and sense of participation to LPs that are not represented on the LPAC. As independent LPAC members are not representatives of any particular LP or group of LPs, unrepresented LPs will perceive them as adding credibility to fund governance. Therefore, independent members should have fiduciary duties, although those should be limited to exercising the specific functions assigned to the LPAC by the fund agreement.
Practical Considerations
The first and most obvious concern that would likely be raised about including one or two independent members is whether that would shift the voting power of the body. It should be apparent, however, that their inclusion would not meaningfully shift the voting dynamics of an LPAC with 5‑15 members. Independent LPAC members can effectuate change without controlling the entity’s voting power because the vote itself is not necessarily what matters but, rather, the discussion preceding the vote.
With that said, there are several material factors and considerations that LPs and GPs need to thoughtfully consider as they move forward with including independent members on their funds’ LPACs.
See “Former Law Firm Partner and Current Independent Director Provides Perspective on Private Fund Governance Issues, Regulatory Matters and Allocator Concerns” (Oct. 27, 2016).
Compensation
A main obstacle to appointing independent LPAC members may be the mutual reluctance of GPs and LPs to bear the compensation, but the magnitude of that issue can be gleaned by evaluating boards of privately held companies. In a 2022 survey of private companies, 70% of which were wholly owned or majority-owned by families, Compensation Advisory Partners found that:
- annual retainer fees correlate to company size, with a median of $65,000 for companies with over $1 billion in annual revenues and a median of $30,000 for all companies;
- 27% of companies paid meeting fees, with a median in‑person meeting fee of $2,500 and a median virtual meeting fee of $1,000; and
- 26% of companies offered long-term equity incentives to independent directors.
The issuance of equity incentives is unlikely to be feasible for LPAC members, as that practice is more prevalent among PE portfolio companies.
A valid parallel between companies and funds, however, is the correlation to size. A survey by Gallagher, another benefit consulting firm, observed a median annual cash retainer of $75,000 for outside directors of large family-owned companies. As a company’s revenues increase, so do the responsibilities of the board, and independent director fees are correspondingly higher. Therefore, it is reasonable to suggest an annual cash retainer fee for independent LPAC members in the $25,000-$75,000 range, depending on fund size and other variables that impact complexity and responsibilities.
GPs and LPs need to ask themselves: do the benefits of independent LPAC members warrant these costs? Considering the deficiencies of current practices, LPs’ dissatisfaction with overall fund governance and the opportunity for GPs to distinguish themselves through innovation, the answer should clearly be “yes.”
Selection Criteria
To be considered independent for these purposes, an LPAC member should not:
- be an investor in any fund managed by the GP in question;
- be affiliated with any GP in the PE industry – not just the GP for the fund in question;
- be affiliated with any LP in any fund managed by the GP in question;
- be affiliated with any institutional LP that invests regularly in PE; or
- serve on the LPAC of any other fund managed by the GP in question.
Who are likely candidates? They should be professionals with PE experience, but the relevant experience relates more to the nuances of fund dynamics and less to the investment focus of the fund. The combination of PE experience and the aforementioned independence standards points toward investment professionals who, due to career change or retirement, are no longer affiliated with a PE firm or institutional investor, as well as former PE lawyers and similar service professionals.
Who should appoint an independent LPAC member? The initiative needs to come from the GP, but one can imagine different appointment processes. For example:
- the GP names the independent LPAC member(s) in the fund’s offering materials;
- after the fund’s first or final closing, the GP nominates the independent LPAC member(s) who must then be approved by the other LPAC members; or
- the GP nominates, say, two candidates for each independent LPAC seat, and the other LPAC members select between the proffered candidates.
Will candidates be concerned about the risk of legal liability associated with fiduciary duties? Yes, but not more than professionals who consider joining a public or private company board. Potential LPAC members should get comfort from the fact that they are indemnified under fund agreements and covered by GP liability insurance policies.
See “Navigating Indemnification and Exculpation Provisions in Fund Documents (Part Two of Two)” (Nov. 2, 2021); and “How E&O and D&O Liability Insurance Can Help Fund Managers Mitigate the Consequences of Regulatory Enforcement Actions” (Jun. 2, 2016).
Conclusion
With all the anticipated benefits of independent LPAC members, why has it not happened yet? Conversations with GPs indicate that the answer has less to do with any particular objections or obstacles, and more with the simple fact that they had not thought about it. LPACs in general are rarely the result of deliberate design.
There is reason to believe, however, that the inclusion of independent members on fund LPACs will quickly become the industry standard after one or a few prominent GPs either include them in the LPACs of their new fund launches or add them to their existing LPACs, as permitted. The cost-benefit analysis clearly points in that direction.
Robert Seber is a partner in the PE group of Vinson & Elkins LLP, where he heads the firm’s fund formation practice.